Clinical Study of the Safety of a Single-port Endoscopic Surgical System for General Surgery
1 other identifier
interventional
10
1 country
1
Brief Summary
This is a small-scale pre-clinical exploratory study to investigate the safety of a novel single-port robotic system for general surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2022
CompletedFirst Submitted
Initial submission to the registry
August 1, 2022
CompletedFirst Posted
Study publicly available on registry
August 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedAugust 5, 2022
August 1, 2022
12 months
August 1, 2022
August 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Conversion rate
The proportion of converted to laparotomy, laparoscopic surgery and added ≥ 2 trocars
intraoperative
Secondary Outcomes (5)
Operative time
intraoperative
Intraoperative blood loss
intraoperative
Length of stay
1-14 days after surgery
Early morbidity rate
30 days after surgery
Incision healing
1-14 days after surgery
Study Arms (1)
Single-port Endoscopic Surgical System
EXPERIMENTALA novel robotic surgical system that can be configured for multi-port, single-port, or hybrid-port procedures. In the single-port configuration, a four-channel trocar shall be used. The surgical tools are steered through the curved access channels in the trocar to enter a patient's abdomen.
Interventions
Robot assisted single-port rectal resection, colectomy, partial gastrectomy, appendectomy and cholecystectomy via the single-port configuration
Eligibility Criteria
You may qualify if:
- years \< age ≤75 years
- Suitable for minimally invasive surgery
- ≤BMI≤28 kg/m2
- ASA score is Ⅰ-Ⅲ
- Informed consent
- Colon and rectal resection: colon and rectal polyps, inflammatory bowel disease, intestinal diverticula, colorectal cancer diagnosed cT3N0M0 with a maximum diameter of ≤4 cm located above the peritoneal reflection.
- Partial gastrectomy: gastric stromal tumor, gastric giant ulcer.
- Appendectomy: chronic appendicitis.
- Cholecystectomy: chronic cholecystitis combined with gallbladder stones, gallbladder polyps (\> 1 cm).
You may not qualify if:
- With other malignancies or a previous history of other malignancies
- Undergone other major surgical treatment within 3 months prior to enrolment or planned during the trial
- With active tuberculosis
- With severe systemic disease
- With long-term use of anticoagulant and anti-platelet drugs (anti-platelet aggregation drugs discontinued less than 1 week prior to surgery), history of bleeding disorders or hematopoietic or coagulation disorders.
- With severe allergies and suspected or established alcohol, drug or substance addiction
- Patients who are immunodeficiency virus (HIV) antibody positive; hepatitis B surface antigen (HbsAg) positive and have a hepatitis B virus DNA (HBV-DNA) copy number above the lower limit of detection or normal range; hepatitis C virus (HCV) antibody positive; syphilis spirochete antibody positive and at high risk of transmission as judged by the investigator.
- Emergency surgery
- Women who are pregnant, breastfeeding or planning to become pregnant during the trial
- Other conditions which, in the opinion of the investigator, make participation in this trial inappropriate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, 201801, China
Related Publications (3)
Grochola LF, Soll C, Zehnder A, Wyss R, Herzog P, Breitenstein S. Robot-assisted versus laparoscopic single-incision cholecystectomy: results of a randomized controlled trial. Surg Endosc. 2019 May;33(5):1482-1490. doi: 10.1007/s00464-018-6430-7. Epub 2018 Sep 14.
PMID: 30218263BACKGROUNDLim MS, Melich G, Min BS. Robotic single-incision anterior resection for sigmoid colon cancer: access port creation and operative technique. Surg Endosc. 2013 Mar;27(3):1021. doi: 10.1007/s00464-012-2549-0. Epub 2012 Oct 10.
PMID: 23052525BACKGROUNDGuo Z, Shi Y, Song Z, Jia W, Wang S, Zhang Y, Ji X, Liu K, Zhang T, Cheng X, Zhao R. Single-incision robotic assisted surgery: a nonrandomized cohort pilot study on a novel surgical platform in colorectal surgery. Int J Surg. 2023 Nov 1;109(11):3417-3429. doi: 10.1097/JS9.0000000000000612.
PMID: 37526117DERIVED
Study Officials
- STUDY CHAIR
Ren Zhao, MD, PHD
Ruijin Hospitlal , Shanghai Jiaotong University School of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 1, 2022
First Posted
August 3, 2022
Study Start
March 7, 2022
Primary Completion
March 1, 2023
Study Completion
March 1, 2023
Last Updated
August 5, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share